Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
6,450.00
-20.6 (-0.32%)
BSENSE

Dec 05

BSE+NSE Vol: 82.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,715.00
2,410.00
2,585.00
2,319.00
2,338.00
2,118.00
2,303.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,715.00
2,410.00
2,585.00
2,319.00
2,338.00
2,118.00
2,303.00
Raw Material Cost
937.00
1,010.00
931.00
1,021.00
976.00
893.00
898.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
6.00
(Increase) / Decrease In Stocks
136.00
-54.00
50.00
-99.00
-7.00
-40.00
-2.00
Employee Cost
354.00
340.00
350.00
297.00
304.00
292.00
297.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
400.00
385.00
368.00
357.00
349.00
351.00
373.00
Total Expenditure (Excl Depreciation)
1,827.00
1,681.00
1,699.00
1,576.00
1,622.00
1,496.00
1,572.00
Operating Profit (PBDIT) excl Other Income
888.00
729.00
886.00
743.00
716.00
622.00
731.00
Other Income
145.00
119.00
86.00
82.00
106.00
79.00
79.00
Operating Profit (PBDIT)
1,033.00
848.00
972.00
825.00
822.00
701.00
810.00
Interest
8.00
3.00
1.00
0.00
1.00
0.00
2.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,025.00
845.00
971.00
825.00
821.00
701.00
808.00
Depreciation
113.00
112.00
107.00
99.00
99.00
97.00
95.00
Profit Before Tax
912.00
733.00
864.00
726.00
722.00
604.00
713.00
Tax
223.00
188.00
202.00
137.00
212.00
174.00
175.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
689.00
545.00
662.00
589.00
510.00
430.00
538.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
689.00
545.00
662.00
589.00
510.00
430.00
538.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
689.00
545.00
662.00
589.00
510.00
430.00
538.00
Equity Capital
53.00
53.00
53.00
53.00
53.00
53.00
53.00
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
26.0
20.57
24.98
22.23
19.25
16.23
20.3
Diluted Earnings per share
25.97
20.49
24.93
22.2
19.2
16.2
20.25
Operating Profit Margin (Excl OI)
32.71%
30.25%
34.27%
32.04%
30.62%
29.37%
31.74%
Gross Profit Margin
37.75%
35.06%
37.56%
35.58%
35.12%
33.1%
35.08%
PAT Margin
25.38%
22.61%
25.61%
25.4%
21.81%
20.3%
23.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 12.66% vs -6.77% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 26.42% vs -17.67% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 21.81% vs -17.72% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 166.67% vs 200.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Divi's Lab. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,715.00
14,478.31
-11,763.31
-81.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,715.00
14,478.31
-11,763.31
-81.25%
Raw Material Cost
937.00
1,621.51
-684.51
-42.21%
Purchase of Finished goods
0.00
1,087.79
-1,087.79
-100.00%
(Increase) / Decrease In Stocks
136.00
273.43
-137.43
-50.26%
Employee Cost
354.00
2,764.79
-2,410.79
-87.20%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
400.00
4,203.74
-3,803.74
-90.48%
Total Expenditure (Excl Depreciation)
1,827.00
9,951.26
-8,124.26
-81.64%
Operating Profit (PBDIT) excl Other Income
888.00
4,527.05
-3,639.05
-80.38%
Other Income
145.00
469.92
-324.92
-69.14%
Operating Profit (PBDIT)
1,033.00
4,996.97
-3,963.97
-79.33%
Interest
8.00
99.86
-91.86
-91.99%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,025.00
4,897.11
-3,872.11
-79.07%
Depreciation
113.00
729.50
-616.50
-84.51%
Profit Before Tax
912.00
4,167.61
-3,255.61
-78.12%
Tax
223.00
1,030.52
-807.52
-78.36%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
689.00
3,137.09
-2,448.09
-78.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
689.00
3,137.09
-2,448.09
-78.04%
Share in Profit of Associates
0.00
-12.14
12.14
100.00%
Minority Interest
0.00
7.00
-7.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
689.00
3,117.95
-2,428.95
-77.90%
Equity Capital
53.00
239.93
-186.93
-77.91%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
26.00
13.00
13.00
100.00%
Diluted Earnings per share
25.97
13.00
12.97
99.77%
Operating Profit Margin (Excl OI)
32.71%
31.43%
0.00
1.28%
Gross Profit Margin
37.75%
34.00%
0.00
3.75%
PAT Margin
25.38%
21.78%
0.00
3.60%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,715.00 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 12.66% vs -6.77% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 16.12% vs 22.47% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 689.00 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 26.42% vs -17.67% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 35.10% vs 46.55% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 888.00 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.81% vs -17.72% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 24.02% vs 49.48% in Sep 2024

Quarterly - Interest
Interest 8.00 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 166.67% vs 200.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 700.00% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.71%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024